WT
RXRX icon

Whittier Trust’s Recursion Pharmaceuticals RXRX Stock Holding History

Whittier Trust’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11K Buy
3,500
+1,500
+75% +$5.8K ﹤0.01% 1108
2025
Q4 		$9.1K Buy
2,000
+800
+67% +$3.96K ﹤0.01% 1149
2025
Q3 		$6.59K Hold
1,200
– – ﹤0.01% 1189
2025
Q2 		$6.07K Hold
1,200
– – ﹤0.01% 1312
2025
Q1 		$6.35K Hold
1,200
– – ﹤0.01% 1283
2024
Q4 		$8.11K Hold
1,200
– – ﹤0.01% 1282
2024
Q3 		$7.91K Buy
+1,200
New +$8.6K ﹤0.01% 1304

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Whittier Trust's RXRX Position: Q1 2026 in Review

Whittier Trust increased its Recursion Pharmaceuticals (RXRX) stake by 75% in Q1 2026, buying an estimated $5.8K and bringing the position to 3,500 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Whittier Trust first reported a position in RXRX in Q3 2024 and has held it in 7 quarters since. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Whittier Trust held 3,500 shares of Recursion Pharmaceuticals worth $11K as of Q1 2026.
  • Whittier Trust bought 1,500 Recursion Pharmaceuticals shares in Q1 2026, an estimated $5.8K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Whittier Trust's portfolio in Q1 2026, its #1108 holding.
  • Whittier Trust first reported a position in Recursion Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.